| | 136236-51-6 Basic information More.. |
| Product Name: | Rasagiline | | Synonyms: | (R)-2,3-DIHYDRO-N-2-PROPYNYL-1H-INDEN-1-AMINE;Rasagiline -13C3;Rasagiline;(R)-N-2-Propynyl-1-indanamine;1H-Inden-1-amine, 2,3-dihydro-N-2-propynyl-, (1R);1-Indanamine, N-2-propynyl-, (R)-;Unii-003N66ts6t;(R)-N-(2-Propynyl)-2,3-dihydroinden-1-aMine | | CAS: | 136236-51-6 | | MF: | C12H13N | | MW: | 171.24 | | EINECS: | | | Mol File: | 136236-51-6.mol |  |
Use
Rasagiline is a second-generation, irreversible monoamine oxidase type B (MAO-B) inhibitor that has been launched for the treatment of Parkinson’s disease (PD). 5HT4 receptor agonist, peristaltic stimulant. Rasagiline, is a selective and irreversible propargylamine inhibitor of monoamine oxidase which has been used to increase the availability of dopamine at striatal receptors as a method to treat Parkinson’s disease.
- Rasagiline
-
- US $34.00-80.00 / mg
- 2025-05-20
- CAS:136236-51-6
- Min. Order:
- Purity: 99.14%
- Supply Ability: 10g
- Rasagiline
-
- US $34.00-80.00 / mg
- 2025-05-20
- CAS:136236-51-6
- Min. Order:
- Purity: 99.14%
- Supply Ability: 10g
- Rasagiline
-
- US $0.00 / KG
- 2025-05-16
- CAS:136236-51-6
- Min. Order: 1KG
- Purity: 99%
- Supply Ability: 50000KG/month
|
|
136236-51-6
Recommend Suppliers |
|